Bone Marrow Risk Assessment

2242 Words9 Pages

If a doctor insists that a patient has leukaemia, more drafted measures should be taken into consideration. Measures which include the use of samples taken from the blood because it is not often the case where signs and symptoms might suggest that the patient have leukaemia, other measures include the results of the physical exam made by the doctor and the samples of cells from the blood, the bone marrow and the spinal fluid.
Before a patient can be diagnosed with AML, a few tests should be done especially those of the bone marrow and spinal fluid.
SAMPLES (This is the beginning of the diagnosis)
Blood samples are taken from the vein of the arm by an injection.
Bone marrow samples are taken in two different …show more content…

Computed tomography (CT) scan
This test can recognise changes done to internal organs faster than a normal x-rays. It is known as a more improved measure but it works just like an x-ray. The procedure of this scan starts when the doctor gives a patient a special injection of a substance that can help find out whether there are chances or damages done to organs such the spleen and others. It also uses a special computing software which allows the doctor to find the perfect image of the damaged organ and where exact is the damage done on that object.

When the scan is done, the patient has to lie down on an object that is narrow and does not move because the scan works only on a narrow surface. The reason why its regarded as better than an x-ray scan is because its results are more accurate and it takes a longer time to work than a normal x- ray …show more content…

Bone marrow transplantation has also been used in this matter because it has evolved over the past decade and It is considered as the only treatment that doctors are impressed with, because it gives patients long survival and is highly recommended to patients who could not be cured by the drugs in a minimum of 10 to 20 days after treatment. Doctors are impressed by the recent progress in the treatment of this disease, as it started or was discovered about three decades ago. Maintenance chemotherapy, immunotherapy, and CNS prophylaxis have little role in AML. It is not yet clear whether the therapy might be effective in the next coming years because even though it is highly recommended, the side of the therapy might cause actual and long-time damage to the patient but if procedure goes accordingly, there should be answers to this question of whether chemotherapy can be accepted as a cure of AML. Future progress in the treatment of AML awaits new and more improved methods for detecting leukaemia and treating it with immediate effect but for now the more effective use of current therapy treatment and the introduction of new effective drugs can be acknowledge and found as a cure to AML until further analysis are made and a more effective treatment is found. Most data suggest that treating a

More about Bone Marrow Risk Assessment

Open Document